Antiplatelet and Anticoagulation Therapies

A risk assessment algorithm combining clinical risk factors and platelet function test results may help interventional cardiologists better identify patients who stand to benefit from intensive antiplatelet medication after percutaneous coronary i...

People with acute coronary syndrome (ACS) who undergo an angioplasty procedure and receive a heart stent are prescribed an oral antiplatelet (OAP) therapy and aspirin to help prevent a heart attack, a blood clot in their heart stent (stent thrombo...

The Medicines Company announced that the U.S. Food and Drug Administration (FDA) Cardiovascular and Renal Drugs Advisory Committee (CRDAC) voted 9 - 2 with one abstention to recommend approval of the investigational intravenous antiplatelet agent...

AstraZeneca announced that the U.S. Food and Drug Administration (FDA) has approved a new administration option for acute coronary syndrome (ACS) patients who are unable to swallow ticagrelor (Brilinta) 90 mg tablets whole. Unlike other P2Y12 inhi...

rivaroxaban, Xarelto, VENTURE-AF, VKA, atrial fibrillation, Heart Rhythm 2015
Janssen Pharmaceuticals Inc. and its development partner Bayer HealthCare announced results from the VENTURE-AF trial. The study explored the potential of once...
antiplatelet medication, prasugrel, clopidogrel, risk algorithm, SCAI
A risk assessment algorithm combining clinical risk factors and platelet function test results may help interventional cardiologists better identify patients...
cilostazol, DAPT, bridge therapy, surgery, bleeding risk, SCAI
Patients with a high-risk paclitaxel drug-eluting stent given the shorter-acting antiplatelet drug cilostazol prior to a surgical procedure safely transitioned...
PROMETHEUS, prasugrel, clopidogrel, heart disease, bleeding, SCAI
Prasugrel (Effient) is more likely to be given to lower-risk heart disease patients undergoing percutaneous coronary intervention (PCI) compared to clopidogrel...
ticagrelor, AstraZeneca, FDA, crushing, option
Ticagrelor (Brilinta) 90 mg tablets from AstraZeneca now have FDA approval to be crushed and administered in water by swallowing or via
The Watchman left atrial appendage closure device from Boston Scientific Corp. is a catheter-delivered heart implant designed to close the...
The Xarelto Starter Pack from Janssen Pharmaceuticals Inc. was designed to help simplify the dosing for the initial 30-day treatment period...
Savaysa (edoxaban) tablets from Daiichi Sankyo Co. Ltd. are an oral, once-daily selective factor Xa-inhibitor to reduce the risk of stroke...

Articles

antiplatelet medication, prasugrel, clopidogrel, risk algorithm, SCAI
A risk assessment algorithm combining clinical risk factors and platelet function test results may help interventional cardiologists better identify patients...
PROMETHEUS, prasugrel, clopidogrel, heart disease, bleeding, SCAI
Prasugrel (Effient) is more likely to be given to lower-risk heart disease patients undergoing percutaneous coronary intervention (PCI) compared to clopidogrel...
heart stent, OAP therapy, ACS, patients, PCNA, SCAI, medication, prescribed
People with acute coronary syndrome (ACS) who undergo an angioplasty procedure and receive a heart stent are prescribed an oral antiplatelet (OAP) therapy and...
The Medicines Company, cangrelor, FDA advisory committee, approval
The Medicines Company announced that the U.S. Food and Drug Administration (FDA) Cardiovascular and Renal Drugs Advisory Committee (CRDAC) voted 9 - 2 with one...

Video Center

There were several technology takeaway messages for the future of electrophysiology (EP) at the...
3 days 18 hours ago
The Heart Rhythm Society’s 36th Annual Scientific Sessions, May 13-16, 2015 in Boston, will offer...
2 weeks 17 hours ago
U.S. healthcare reform is largely being driven through adoption of new information technology (IT...
4 weeks 4 days ago
The webinar Maximize Your Clinical Imaging With a VNA Strategy will explain the changing face of medical imaging and data, and the challenges to...
Centricity, webinar, ZFV, ZFP, viewer, remote viewing system, enterprise
Healthcare organizations are demanding more capabilities for image viewers accessed by clinicians. Zero footprint (ZFP) viewers provide imaging tools from...
The webinar "State of the Art in MRI Pediatric Brain Perfusion Imaging" educates participants about the state of the art clinical and emerging translational...

Comparison Charts

Sorry there is no data available